Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast CancerW. Fraser Symmans, Smita Asare, Xiuzhen Duan et al.|JAMA Oncology|2021Cited by 110
Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteinsAn Zou, Nikki Cheng, Diana Lambert et al.|BMC Cancer|2014Cited by 95
CD44s Expression is Reduced in Endometriotic Lesions Compared to Eutopic Endometrium in Women with EndometriosisWarren B. Nothnick, Ossama Tawfik, Fang Fan et al.|International Journal of Gynecological Pathology|2001Cited by 4
Additional file 3: of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S. Elsarraj, Fariba Behbod, Yan Hong et al.|Figshare|2015Cited by 0
Additional file 10: of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S. Elsarraj, Fariba Behbod, Kelli E. Valdez et al.|Figshare|2015Cited by 0